DarioHealth Corp (DRIO)

NASD · Healthcare · Health Information Services · USA

DarioHealth Corp is a micro cap company (market value under $300 million) in the Health Information Services industry.

DarioHealth is a vertically integrated health intelligence platform combining connected hardware devices, artificial intelligence, and behavior change coaching for chronic condition management. The company serves employers, health plans, and pharmaceutical companies through a subscription model, addressing diabetes, hypertension, obesity, and mental health through digital self-care with virtual coaching and clinical services.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the DarioHealth Corp stock.

Our verdict on DRIO

No reliable verdict: intrinsic value $56.58 per share, market price $1.15 (as of 2026-11-17).

Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $56.58: 49 times the price of $1.15. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.

ETFs with the most weight in DRIO

Browse

Peers in Health Information Services

All 40 Health Information Services stocks

Is DRIO undervalued or overvalued?

We do not publish a verdict on DRIO. Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $56.58: 49 times the price of $1.15. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.

What is the intrinsic value of DRIO?

We do not publish one (as of the 2026-11-17 close). Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $56.58: 49 times the price of $1.15. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.